vs
亚什兰（ASH）与NATIONAL HEALTHCARE CORP（NHC）财务数据对比。点击上方公司名可切换其他公司
NATIONAL HEALTHCARE CORP的季度营收约是亚什兰的1.0倍（$386.5M vs $386.0M），NATIONAL HEALTHCARE CORP净利率更高（6.4% vs -3.1%，领先9.5%），NATIONAL HEALTHCARE CORP同比增速更快（4.6% vs -4.7%），亚什兰自由现金流更多（$111.0M vs $6.4M），过去两年NATIONAL HEALTHCARE CORP的营收复合增速更高（14.0% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
HCA Healthcare是1968年成立的美国营利性医疗服务运营商，总部位于田纳西州纳什维尔。截至2020年5月，该公司在全美20个州及英国持有并运营186家医院，还有约2400个医疗服务网点，涵盖手术中心、独立急诊室、紧急护理中心及医师诊所，2024年位列美国财富500强第61位。
ASH vs NHC — 直观对比
营收规模更大
NHC
是对方的1.0倍
$386.0M
营收增速更快
NHC
高出9.3%
-4.7%
净利率更高
NHC
高出9.5%
-3.1%
自由现金流更多
ASH
多$104.6M
$6.4M
两年增速更快
NHC
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $386.5M |
| 净利润 | $-12.0M | $24.8M |
| 毛利率 | 27.2% | — |
| 营业利润率 | -1.6% | 8.6% |
| 净利率 | -3.1% | 6.4% |
| 营收同比 | -4.7% | 4.6% |
| 净利润同比 | 92.7% | 308.6% |
| 每股收益（稀释后） | $-0.26 | $1.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHNHC
| Q4 25 | $386.0M | $386.5M | ||
| Q3 25 | $477.0M | $382.7M | ||
| Q2 25 | $463.0M | $374.9M | ||
| Q1 25 | $479.0M | $373.7M | ||
| Q4 24 | $405.0M | $369.4M | ||
| Q3 24 | $521.0M | $340.2M | ||
| Q2 24 | $544.0M | $300.7M | ||
| Q1 24 | $575.0M | $297.2M |
净利润ASHNHC
| Q4 25 | $-12.0M | $24.8M | ||
| Q3 25 | $31.0M | $39.2M | ||
| Q2 25 | $-742.0M | $23.7M | ||
| Q1 25 | $31.0M | $32.2M | ||
| Q4 24 | $-165.0M | $6.1M | ||
| Q3 24 | $17.0M | $42.8M | ||
| Q2 24 | $6.0M | $26.8M | ||
| Q1 24 | $120.0M | $26.2M |
毛利率ASHNHC
| Q4 25 | 27.2% | — | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 28.5% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 27.4% | — | ||
| Q3 24 | 33.2% | — | ||
| Q2 24 | 34.2% | — | ||
| Q1 24 | 28.0% | — |
营业利润率ASHNHC
| Q4 25 | -1.6% | 8.6% | ||
| Q3 25 | 12.8% | 7.9% | ||
| Q2 25 | -152.9% | 9.1% | ||
| Q1 25 | 10.6% | 8.2% | ||
| Q4 24 | -44.2% | 7.8% | ||
| Q3 24 | 6.1% | 6.7% | ||
| Q2 24 | -11.2% | 7.5% | ||
| Q1 24 | 3.7% | 5.3% |
净利率ASHNHC
| Q4 25 | -3.1% | 6.4% | ||
| Q3 25 | 6.5% | 10.3% | ||
| Q2 25 | -160.3% | 6.3% | ||
| Q1 25 | 6.5% | 8.6% | ||
| Q4 24 | -40.7% | 1.6% | ||
| Q3 24 | 3.3% | 12.6% | ||
| Q2 24 | 1.1% | 8.9% | ||
| Q1 24 | 20.9% | 8.8% |
每股收益（稀释后）ASHNHC
| Q4 25 | $-0.26 | $1.58 | ||
| Q3 25 | $0.83 | $2.50 | ||
| Q2 25 | $-16.21 | $1.52 | ||
| Q1 25 | $0.65 | $2.07 | ||
| Q4 24 | $-3.50 | $0.38 | ||
| Q3 24 | $0.34 | $2.73 | ||
| Q2 24 | $0.12 | $1.73 | ||
| Q1 24 | $2.39 | $1.69 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $92.8M |
| 总债务越低越好 | $1.4B | $40.0M |
| 股东权益账面价值 | $1.9B | $1.1B |
| 总资产 | $4.5B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.74× | 0.04× |
8季度趋势，按日历期对齐
现金及短期投资ASHNHC
| Q4 25 | $304.0M | $92.8M | ||
| Q3 25 | $215.0M | $130.6M | ||
| Q2 25 | $207.0M | $111.0M | ||
| Q1 25 | $168.0M | $90.4M | ||
| Q4 24 | $219.0M | $76.1M | ||
| Q3 24 | $300.0M | $84.8M | ||
| Q2 24 | $399.0M | $136.2M | ||
| Q1 24 | $439.0M | $94.0M |
总债务ASHNHC
| Q4 25 | $1.4B | $40.0M | ||
| Q3 25 | $1.4B | $73.1M | ||
| Q2 25 | $1.4B | $110.0M | ||
| Q1 25 | $1.3B | $134.0M | ||
| Q4 24 | $1.3B | $137.0M | ||
| Q3 24 | $1.3B | $147.0M | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.3B | — |
股东权益ASHNHC
| Q4 25 | $1.9B | $1.1B | ||
| Q3 25 | $1.9B | $1.1B | ||
| Q2 25 | $1.9B | $1.0B | ||
| Q1 25 | $2.6B | $1.0B | ||
| Q4 24 | $2.6B | $980.2M | ||
| Q3 24 | $2.9B | $983.5M | ||
| Q2 24 | $3.0B | $945.8M | ||
| Q1 24 | $3.1B | $924.7M |
总资产ASHNHC
| Q4 25 | $4.5B | $1.5B | ||
| Q3 25 | $4.6B | $1.6B | ||
| Q2 25 | $4.6B | $1.6B | ||
| Q1 25 | $5.2B | $1.5B | ||
| Q4 24 | $5.2B | $1.5B | ||
| Q3 24 | $5.6B | $1.6B | ||
| Q2 24 | $5.7B | $1.3B | ||
| Q1 24 | $5.9B | $1.3B |
负债/权益比ASHNHC
| Q4 25 | 0.74× | 0.04× | ||
| Q3 25 | 0.73× | 0.07× | ||
| Q2 25 | 0.73× | 0.11× | ||
| Q1 25 | 0.52× | 0.13× | ||
| Q4 24 | 0.51× | 0.14× | ||
| Q3 24 | 0.47× | 0.15× | ||
| Q2 24 | 0.45× | — | ||
| Q1 24 | 0.42× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $16.8M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $6.4M |
| 自由现金流率自由现金流/营收 | 28.8% | 1.7% |
| 资本支出强度资本支出/营收 | 3.6% | 2.7% |
| 现金转化率经营现金流/净利润 | — | 0.68× |
| 过去12个月自由现金流最近4个季度 | $200.0M | $148.6M |
8季度趋势，按日历期对齐
经营现金流ASHNHC
| Q4 25 | $125.0M | $16.8M | ||
| Q3 25 | $40.0M | $66.2M | ||
| Q2 25 | $115.0M | $62.8M | ||
| Q1 25 | $9.0M | $39.3M | ||
| Q4 24 | $-30.0M | $12.8M | ||
| Q3 24 | $80.0M | $34.2M | ||
| Q2 24 | $127.0M | $50.7M | ||
| Q1 24 | $54.0M | $9.6M |
自由现金流ASHNHC
| Q4 25 | $111.0M | $6.4M | ||
| Q3 25 | $6.0M | $56.5M | ||
| Q2 25 | $95.0M | $52.6M | ||
| Q1 25 | $-12.0M | $33.1M | ||
| Q4 24 | $-53.0M | $4.6M | ||
| Q3 24 | $42.0M | $28.6M | ||
| Q2 24 | $98.0M | $42.8M | ||
| Q1 24 | $20.0M | $3.7M |
自由现金流率ASHNHC
| Q4 25 | 28.8% | 1.7% | ||
| Q3 25 | 1.3% | 14.8% | ||
| Q2 25 | 20.5% | 14.0% | ||
| Q1 25 | -2.5% | 8.9% | ||
| Q4 24 | -13.1% | 1.3% | ||
| Q3 24 | 8.1% | 8.4% | ||
| Q2 24 | 18.0% | 14.2% | ||
| Q1 24 | 3.5% | 1.2% |
资本支出强度ASHNHC
| Q4 25 | 3.6% | 2.7% | ||
| Q3 25 | 7.1% | 2.5% | ||
| Q2 25 | 4.3% | 2.7% | ||
| Q1 25 | 4.4% | 1.6% | ||
| Q4 24 | 5.7% | 2.2% | ||
| Q3 24 | 7.3% | 1.7% | ||
| Q2 24 | 5.3% | 2.6% | ||
| Q1 24 | 5.9% | 2.0% |
现金转化率ASHNHC
| Q4 25 | — | 0.68× | ||
| Q3 25 | 1.29× | 1.69× | ||
| Q2 25 | — | 2.65× | ||
| Q1 25 | 0.29× | 1.22× | ||
| Q4 24 | — | 2.10× | ||
| Q3 24 | 4.71× | 0.80× | ||
| Q2 24 | 21.17× | 1.89× | ||
| Q1 24 | 0.45× | 0.37× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
NHC
| Inpatient Services Segment | $333.7M | 86% |
| Homecare Services Segment | $40.0M | 10% |
| Other | $11.2M | 3% |
| National | $1.6M | 0% |
